Bowling Portfolio Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$1.52M Sell
4,712
-656
-12% -$208K 0.42% 76
2022
Q2
$1.74M Buy
+5,368
New +$1.61M 0.44% 73
2021
Q2
Sell
-5,386
Closed -$1.01M 220
2021
Q1
$1.01M Sell
5,386
-5,720
-52% -$1.12M 0.24% 139
2020
Q4
$1.88M Sell
11,106
-954
-8% -$142K 0.44% 59
2020
Q3
$1.78M Buy
+12,060
New +$1.87M 0.4% 55
2019
Q2
Sell
-30,644
Closed -$3.98M 366
2019
Q1
$3.98M Sell
30,644
-977
-3% -$119K 0.63% 28
2018
Q4
$3.66M Sell
31,621
-629
-2% -$70.3K 0.65% 26
2018
Q3
$3.46M Sell
32,250
-6,737
-17% -$674K 0.48% 58
2018
Q2
$3.33M Buy
+38,987
New +$3.2M 0.46% 64
2018
Q1
Sell
-51,062
Closed -$4.31M 385
2017
Q4
$4.31M Buy
+51,062
New +$4.34M 0.57% 47

Other funds holding LLY

Bowling Portfolio Management's LLY Position: Q3 2022 in Review

Bowling Portfolio Management reduced its Eli Lilly (LLY) stake by 12% in Q3 2022, selling an estimated $208K and leaving 4,712 shares worth $1.52M. The position accounts for 0.42% of the portfolio, ranked #76.

Bowling Portfolio Management first reported a position in LLY in Q4 2017 and has held it in 10 quarters since. The position peaked at $4.31M in Q4 2017. 2,485 funds tracked by Wall St. Rank hold LLY as of Q3 2022.

  • Bowling Portfolio Management held 4,712 shares of Eli Lilly worth $1.52M as of Q3 2022.
  • Bowling Portfolio Management sold 656 Eli Lilly shares in Q3 2022, an estimated $208K.
  • Eli Lilly made up 0.42% of Bowling Portfolio Management's portfolio in Q3 2022, its #76 holding.
  • Bowling Portfolio Management first reported a position in Eli Lilly in Q4 2017 and has held it in 10 quarters since.
  • Bowling Portfolio Management's Eli Lilly position peaked at $4.31M in Q4 2017.
  • 2,485 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2022.

Based on Bowling Portfolio Management's 13F filing for Q3 2022, filed 4 Oct 2022.